BeyondSpring Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

On November 12, 2021 BeyondSpring (the "Company" or "BeyondSpring") (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, reported that management will present at and host one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021 (Press release, BeyondSpring Pharmaceuticals, NOV 12, 2021, View Source;utm_medium=rss&utm_campaign=beyondspring-pharmaceuticals-to-present-at-the-2021-jefferies-london-healthcare-conference [SID1234595381]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be available on-demand for attendees during the virtual conference beginning on November 18, 2021. Investors who would like to view the presentation or request a meeting with management may do so by clicking on the link and registering for the event HERE.

A replay of the presentation will also be available on BeyondSpring’s website on the Events & Presentations page for 30 days following the conclusion of the conference.